Literature DB >> 21946027

The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.

S Alonso1, E Ferrero, M Donat, G Martínez, C Vargas, M Hidalgo, E Moreno.   

Abstract

BACKGROUND: Amino-terminal procollagen propeptide of type I collagen (P1NP) and cross-linked C-terminal telopeptide of type I collagen (βCTX) are two of the more sensitive bone markers for reflecting and monitoring patients with an increased bone turnover as observed in primary hyperparathyroidism (PHPT) patients. AIM: The present study was performed to evaluate the trend of type I collagen markers one year after parathyroidectomy (PTX) and to examine the relationships between serum P1NP and βCTX levels and bone mineral density (BMD) change after PTX in PHPT Spanish patients.
MATERIALS AND METHODS: Fifty-three PHPT patients were enroled and were followed for one year by measuring lumbar BMD, lumbar t-score, lumbar z-score, PTH, calcium, phosphorus, P1NP and βCTX.
RESULTS: Pre-surgery concentrations of both markers were elevated (P1NP: 90.71±5.03; βCTX: 1.52±0.44). A significant decrease was observed in mean post-operative βCTX and P1NP concentrations (p<0.0001). Levels of BMD, t-score and z-score at lumbar spine were relatively low (BMD: 0.75±0.16; z-score -0.90±0.23; t-score -2.51±0.32); after PTX a significant increase was observed in the levels of these three parameters. P1NP and βCTX were correlated with lumbar BMD change one year after PTX (P1NP: r=0.79, p=0.016; βCTX: r=0.89, p=0.003).
CONCLUSIONS: Pre-surgery concentrations of both bone markers were elevated and a significant decrease after PTX was found. Serum βCTX and P1NP levels were potently related to lumbar BMD changes over one year after PTX. The measurement of βCTX and P1NP would be useful to predict long-term changes in lumbar BMD after PTX.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946027     DOI: 10.3275/7923

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy.

Authors:  P Christiansen; T Steiniche; K Brixen; I Hessov; F Melsen; L Heickendorff; L Mosekilde
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

2.  Short-term effects of surgery in post-menopausal patients with primary hyperparathyroidism and normal bone turnover.

Authors:  V Carnevale; M T Pacitti; M Pileri; F Paglia; A Scillitani; S Dionisi; P Caravella; E Romagnoli; S Minisola
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

3.  The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  H Kaji; R Nomura; M Yamauchi; K Chihara; T Sugimoto
Journal:  Horm Metab Res       Date:  2006-06       Impact factor: 2.936

4.  Prediction of bone mass gain by bone turnover parameters after parathyroidectomy for primary hyperparathyroidism: neural network software statistical analysis.

Authors:  Ennio Leopaldi; Luca Angelo Paolino; Maurizio Bevilacqua; Giulio Montecamozzo; Ligia Juliana Dominguez; Luigi Stefano Schipani; Angelo Maria Taschieri
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

5.  Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  D Nakaoka; T Sugimoto; T Kobayashi; T Yamaguchi; A Kobayashi; K Chihara
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

6.  Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism.

Authors:  Y Tanaka; H Funahashi; T Imai; Y Tominaga; H Takagi
Journal:  Semin Surg Oncol       Date:  1997 Mar-Apr

7.  Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.

Authors:  C Y Guo; W E Thomas; A W al-Dehaimi; A M Assiri; R Eastell
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

8.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Authors:  P Garnero; E Sornay-Rendu; M C Chapuy; P D Delmas
Journal:  J Bone Miner Res       Date:  1996-03       Impact factor: 6.741

9.  Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients.

Authors:  G Coen; S Mazzaferro; E De Antoni; S Chicca; P DiSanza; L Onorato; A Spurio; D Sardella; M Trombetta; M Manni
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

10.  Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study.

Authors:  Yoshiaki Tamura; Atsushi Araki; Yuko Chiba; Seijiro Mori; Takayuki Hosoi; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

View more
  5 in total

1.  Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; Barbara C Silva; Yu-Kwang Donovan Tay; John M Williams; Sanchita Agarwal; Beatriz Omeragic; X Edward Guo; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 2.  Bone turnover markers in primary hyperparathyroidism.

Authors:  Aline G Costa; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

3.  Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.

Authors:  Mei Li; Yan Li; Weimin Deng; Zhenlin Zhang; Zhongliang Deng; Yingying Hu; Weibo Xia; Ling Xu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

4.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

Review 5.  Primary Hyperparathyroidism.

Authors:  Leonardo Bandeira; John Bilezikian
Journal:  F1000Res       Date:  2016-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.